Results 181 to 190 of about 1,688 (193)

Dietary restriction of tyrosine and phenylalanine lowers tyrosinemia associated with nitisinone therapy of alkaptonuria

Journal of Inherited Metabolic Disease, 2020
Juliette H Hughes, Hazel Sutherland, Shirley Judd   +2 more
exaly  

Nitisinone treatment during two pregnancies and breastfeeding in a woman with tyrosinemia type 1 – a case report

Journal of Pediatric Endocrinology and Metabolism, 2022
Thomas Zoggeler, Gabriele Ramoser, Nils Janzen   +2 more
exaly  

NMR Spectroscopy Study of Enol–Enol Tautomerism of Nitisinone in Solutions

Pharmaceutical Chemistry Journal, 2021
N E Kuz'Mina, S V Moiseev, A I Luttseva
exaly  

LC-MS/MS study of the degradation processes of nitisinone and its by-products

Journal of Pharmaceutical and Biomedical Analysis, 2019
Hanna Barchańska, Rafał Rola, Wojciech Szczepankiewicz   +2 more
exaly  

Experience of nitisinone for the pharmacological treatment of hereditary tyrosinaemia type 1

Expert Opinion on Pharmacotherapy, 2008
Saikat Santra
exaly  

NITISINONE

2004
openaire   +1 more source

Non randomized study on the potential of nitisinone to inhibit cytochrome P450 2C9, 2D6, 2E1 and the organic anion transporters OAT1 and OAT3 in healthy volunteers

European Journal of Clinical Pharmacology, 2018
Birgitta Olsson
exaly  

Nitisinone in the Treatment of Hereditary Tyrosinaemia Type 1

Drugs, 2012
Patrick McKiernan
exaly  

Simultaneous quantification of succinylacetone and nitisinone for therapeutic drug monitoring in the treatment of Tyrosinemia type 1

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2018
Jonas Sundberg, Flemming Wibrand, Allan M Lund   +2 more
exaly  

Nitisinone use in hereditary tyrosinemia and alkaptonuria

2010
Wendy J. Introne, Kevin J. O'Brien, William A. Gahl   +2 more
openaire   +1 more source